GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abbisko Cayman Ltd (STU:8ZD) » Definitions » Market Cap

Abbisko Cayman (STU:8ZD) Market Cap : €259.66 Mil (As of May. 23, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Abbisko Cayman Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Abbisko Cayman's share price for the quarter that ended in Dec. 2023 was €0.412. Abbisko Cayman's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 647.86 Mil. Therefore, Abbisko Cayman's market cap for the quarter that ended in Dec. 2023 was €266.92 Mil.

Abbisko Cayman's quarterly market cap declined from Dec. 2022 (€227.90 Mil) to Jun. 2023 (€199.54 Mil) but then increased from Jun. 2023 (€199.54 Mil) to Dec. 2023 (€266.92 Mil).

Abbisko Cayman's annual market cap increased from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€227.90 Mil) and increased from Dec. 2022 (€227.90 Mil) to Dec. 2023 (€266.92 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Abbisko Cayman's Enterprise Value for Today is €8.53 Mil.


Abbisko Cayman Market Cap Historical Data

The historical data trend for Abbisko Cayman's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbisko Cayman Market Cap Chart

Abbisko Cayman Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
- - - 227.90 266.92

Abbisko Cayman Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Market Cap Get a 7-Day Free Trial - 265.97 227.90 199.54 266.92

Competitive Comparison of Abbisko Cayman's Market Cap

For the Biotechnology subindustry, Abbisko Cayman's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbisko Cayman's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Abbisko Cayman's Market Cap distribution charts can be found below:

* The bar in red indicates where Abbisko Cayman's Market Cap falls into.



Abbisko Cayman Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Abbisko Cayman's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=€0.412*647.858
=€266.92

Abbisko Cayman's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=€0.412*647.858
=€266.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abbisko Cayman  (STU:8ZD) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Abbisko Cayman Market Cap Related Terms

Thank you for viewing the detailed overview of Abbisko Cayman's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbisko Cayman (STU:8ZD) Business Description

Traded in Other Exchanges
Address
Building 3, No. 898 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, CHN
Abbisko Cayman Ltd is a investment holding company it operates through its subsidiaries which is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative and differentiated small molecule oncology therapies. The company has only one business segment which is the development of innovative medicines.

Abbisko Cayman (STU:8ZD) Headlines

No Headlines